跳至主要内容
临床试验/NL-OMON56613
NL-OMON56613尚未招募不适用

anguage, speech and motor function in mild cognitive impairment due to AD and Alzheimer*s disease - Language, speech, motor function in MCI due to AD and AD

Hanzehogeschool Groningen0 个研究点目标入组 208 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
208

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • In order to be eligible to participate in this study:
  • A subject with MCI with a likelihood of underlying AD pathophysiology must meet
  • the following criteria:
  • * Established diagnosis of MCI due to AD with a likelihood according to NIA-AA
  • criteria (Albert et al., 2011).
  • * A score of stage three on the Global Deterioration Scale (GDS) (Reisberg et
  • al., 1982).
  • A subject with AD must meet the following criteria:
  • * Established diagnosis of AD (amnestic or non-amnestic) or etiologically mixed
  • presentation of AD according to DSM-5 (American Psychiatric Association, 2013)
  • or NINCDS-ARDRA criteria (Jack et al., 2018; McKann et al., 2011).
  • * The following scores on the Global Deterioration Scale (GDS): four for mild
  • AD, five for moderate AD (Reisberg et al., 1982).
  • All subjects of the control group must meet the following criteria:
  • * A score of stage one or two on the Global Deterioration Scale (GDS) (Reisberg
  • et al., 1982).
  • * They are age-matched with the MCI due to AD or AD patients included in the
  • All subjects must meet the following criteria:
  • * First language is Dutch and/or Frisian.
  • * Able to walk independently with or without walking aid.
  • * Able to squeeze with each hand.

排除标准

  • A subject with MCI due to AD or AD who meets the following criteria will be
  • excluded from participation in this study:
  • * Having a neurological or neurodegenerative disease or disorder that may be
  • contributing to cognitive impairment above and beyond that caused by AD or
  • mixed AD; Down*s syndrome, other subtypes of dementia, autism spectrum disorder.
  • * Having an established diagnosis of a psychiatric disorder, e.g.
  • schizophrenia, depression.
  • All subjects in the control group who meets following criteria will be excluded
  • from participation in this study:
  • * Suffers from a neurological, neurodegenerative or psychiatric disease or
  • All subjects in any group who meet any of the following criteria will be
  • excluded from participation in this study:
  • * Hearing loss (with or without hearing aid) that affects communication.
  • * Vision loss (with or without glasses or lenses) that affects communication.
  • * History of language problems, speech problems or dyslexia.
  • * Suffers from additional disorders or diseases which may limit gait, hand grip
  • strength, language and/or speech.
  • * Medication use that influence gait, hand grip strength, speech or language
  • performance at time of testing.
  • * Being terminally ill (i.e., life expectancy < 2 weeks according to the
  • attending physician).

研究者

发起方
Hanzehogeschool Groningen

相似试验